At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter., Rand., Double-Blind, Titration Study to Evaluate & Compare the Efficacy & Safety of Ezetimibe Plus Atorvastatin Vs Atorvastatin in Hypercholesterolemic Pts. at Moderately High Risk for CHD Not Adequately Controlled on Atorvastatin 20 Mg
In Brief
A Phase 3 clinical trial evaluating Comparator: atorvastatin, Comparator: Placebo, and 2 other interventions for Hypercholesterolemia. Completed, enrolled 196 participants.
Detailed Summary
The purpose of this study is to evaluate and compare the efficacy and safety of ezetimibe plus atorvastatin versus atorvastatin in hypercholesterolemic patients at moderately high risk for coronary heart disease not adequately controlled on atorvastatin 20 mg.
Study Details
Timeline
Interventions
Atorvastatin 40mg tablet po qd (by mouth, once a day) for 6 weeks
Atorvastatin 20mg Pbo and ezetimibe 10mg Pbo tablets po qd (by mouth, once a day). for 6 weeks
Atorvastatin 20mg and ezetimibe 10mg tablets po qd (by mouth, once a day). for 6 weeks.
Atorvastatin 40mg Pbo tablets po qd (by mouth, once a day). for 6 weeks.